Careers  |  Media  |  Contact us

PDL1 -SP- 142

Test Name

PDL1 -SP- 142

Home Collection, Lab Visit

Test Code

P0060

Test Components/ Genes/ Parameters

PD-L1 SP142

Sample Report

Click on Icon

Test Information

TAT DETAILS

4 Days

PRE-TEST INSTRUCTIONS

Submit formalin fixed paraffin embedded Tissue Block. Ship at room temperature

CLINICAL UTILITY

PD-L1 testing may be considered for patients with specific types of malignancies to predict response to specific immune checkpoint inhibitors. There are several interpretive scoring systems available for PD-L1 testing, including the tumor proportion score (TPS), the combined positive score (CPS), and tumor-infiltrating immune cell (IC) staining assessments

SPECIMEN STABILITY

Transport at ambient (18-25°C) temperature

METHODOLOGY

IHC

STORAGE TEMPERATURE

NA

SPECIMEN TYPE

Surgical tissue/Tissue Block

Frequently Asked Questions

PDL1 -SP- 142
PD-L1 testing may be considered for patients with specific types of malignancies to predict response to specific immune checkpoint inhibitors.
The patient should carry the FFPE tissue or block of the Lung. This process is carried out by Breast Surgeon in the hospital
The test is recommended in Head & Neck Cancers, NSCLC, Urothelial Cancers to decide immunotherapy benefit to the patients
The test is performed by IHC technique
There is no risk associated with the test as biopsy will be taken by the trained surgeon in the hospital under anasthesia
PD-L1SP142 IHC with CPS interpretation for pembrolizumab therapy